QT dispersion after beta-blocker therapy (carvedilol or metoprolol) in children with heart failure.
Etheridge
Susan P
SP
Division of Cardiology, Department of Pediatrics, University of Utah and Primary Children's Medical Center, 100 North Medical Drive, Salt Lake City, UT 84113, USA. pcsether@ihc.com
Shaddy
Robert E
RE
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D002648:Child; D002669:Child Welfare; D002675:Child, Preschool; D004562:Electrocardiography; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D007223:Infant; D007229:Infant Welfare; D008133:Long QT Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D008790:Metoprolol / Q000627:therapeutic use; D011412:Propanolamines / Q000627:therapeutic use; D012189:Retrospective Studies; D013318:Stroke Volume / Q000502:physiology; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D008790:Metoprolol